Latest gout Stories
SAN DIEGO, Jan. 6, 2011 /PRNewswire/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced positive, preliminary, top-line results from its Phase 2b study of RDEA594 in combination with the current standard of care for the treatment of gout, allopurinol.
BURLINGTON, Mass., Dec.
EXTON, Pa., Dec. 8, 2010 /PRNewswire/ -- BioTrends Research Group, Inc.
EAST BRUNSWICK, N.J., Nov. 30, 2010 /PRNewswire/ -- Savient Pharmaceuticals, Inc.
SHENYANG, China, Nov. 29, 2010 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.
EXTON, Pa., Nov. 23, 2010 /PRNewswire/ -- BioTrends Research Group, Inc. is pleased to announce the recent publication of a syndicated report, TreatmentTrendsÂ®: Gout.
Consumption of fructose-rich beverages, such as sugar-sweetened sodas and orange juice is associated with an increased risk of gout among women.
Consumption of fructose-rich beverages, such as sugar-sweetened sodas and orange juice is associated with an increased risk of gout among women, although their contribution to the risk of gout in the population is likely modest because of the low incidence rate among women.
SAN DIEGO, Nov. 9, 2010 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc.
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.